| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/29/2002 | US6342231 Haemophilus parasuis vaccine and diagnostic |
| 01/29/2002 | US6342230 Materials and methods for prevention or reduction of the severity of heartwater |
| 01/29/2002 | US6342228 Diagnostic kits comprising genetically engineered human immunodeficiency virus-like particles containing heterologous antigenic markers |
| 01/29/2002 | US6342226 Administering antigen combined with a particulate vector, the particulate vector consisting of a non-liquid hydrophilic core for increasing the immunogenicity of an antigen |
| 01/29/2002 | US6342224 For prophylaxis and therapy of human papilloma induced tumours |
| 01/29/2002 | US6342222 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 01/29/2002 | US6342221 Antibody conjugate compositions for selectively inhibiting VEGF |
| 01/29/2002 | US6342220 Agonist antibodies |
| 01/29/2002 | US6342219 As anti-angiogenic and in tumor therapy |
| 01/29/2002 | US6342216 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 01/29/2002 | US6342215 Mutant microorganism having reduced adaptation to particular environment; avirulent pathogens for vaccines |
| 01/29/2002 | CA2226714C Method for identifying the attenuated varicella virus oka strain or a strain derived therefrom |
| 01/29/2002 | CA2194555C Implanted device containing tumor cells for the treatment of cancer |
| 01/29/2002 | CA2158575C Chlamydia vaccine and process |
| 01/28/2002 | CA2352645A1 Compositions for dna transfection |
| 01/24/2002 | WO2002006515A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/24/2002 | WO2002006502A2 Adenovirus vectors comprising introns |
| 01/24/2002 | WO2002006492A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
| 01/24/2002 | WO2002006460A2 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | WO2002006453A2 Regulation of human desc1-like serine protease |
| 01/24/2002 | WO2002006344A2 Rtvp based compositions and methods for the treatment of prostate cancer |
| 01/24/2002 | WO2002006340A2 Tetraspan protein and uses thereof |
| 01/24/2002 | WO2002006338A1 Vaccine comprising a lung tumour associated antigen |
| 01/24/2002 | WO2002006323A1 IMMUNOGENIC PROTEINS DERIVED FROM DOMESTIC MITE ALLERGEN, BLOMIA TROPICALIS (Bt5) |
| 01/24/2002 | WO2002006317A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | WO2002006303A2 Dna vaccines encoding hiv accessory proteins |
| 01/24/2002 | WO2002005851A2 Enhancement of the action of central and peripheral nervous system agents |
| 01/24/2002 | WO2002005849A2 Transportation of nucleic acid substances |
| 01/24/2002 | WO2002005846A1 Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis b surface antigen, and preparation method thereof |
| 01/24/2002 | WO2002005845A1 Immunological combinations for prophylaxis and therapy of helicobacter pylori infection |
| 01/24/2002 | WO2002005844A2 Protein complex serving as a vehicle for orally administerable medicaments |
| 01/24/2002 | WO2002005843A2 Human rrp sequences and methods of use |
| 01/24/2002 | WO2002005842A2 Preventing airway mucus production by administration of egf-r antagonists |
| 01/24/2002 | WO2002005791A2 Antitumor combination comprising an aromatase inhibitor and an egfr antagonist or inhibitor |
| 01/24/2002 | WO2001075111A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/24/2002 | WO2001070767A3 Therapeutic anti-melanoma compounds |
| 01/24/2002 | WO2001064750A3 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 01/24/2002 | WO2001060838A3 Aids ancestral viruses and vaccines |
| 01/24/2002 | WO2001059073A3 Cytotoxic t lymphocytes activated by dendritic cell hybrids |
| 01/24/2002 | WO2001058481A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 01/24/2002 | WO2001052878A3 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 01/24/2002 | WO2001046258A3 Transporters and ion channels |
| 01/24/2002 | WO2001044288A3 Toscana virus nucleoprotein |
| 01/24/2002 | WO2001044286A3 Five-helix protein |
| 01/24/2002 | WO2001042465A3 Chordin-like molecules and uses thereof |
| 01/24/2002 | WO2001039797A3 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 01/24/2002 | WO2001038498A3 A new genotype of hepatitis b virus |
| 01/24/2002 | WO2001036977A8 Identification of disease markers involving mass-based-separation |
| 01/24/2002 | WO2001036470A3 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 01/24/2002 | WO2001036005A3 Targeted delivery of therapeutic and diagnostic moieties |
| 01/24/2002 | WO2001034795A3 Casb7435 polypeptide, nucleic acid encoding it, and their uses in treatment and diagnosis |
| 01/24/2002 | WO2001034768A3 15 human secreted proteins |
| 01/24/2002 | WO2001032154A3 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 01/24/2002 | WO2001027276A3 Dna sequences from breast tumor and uses thereof |
| 01/24/2002 | WO2001025436A3 Endozepine-like polypeptides and polynucleotides encoding same |
| 01/24/2002 | WO2001019860A3 Proteins associated with cell differentiation |
| 01/24/2002 | WO2001019855A3 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 01/24/2002 | WO2001015511A3 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 01/24/2002 | WO2000073338A9 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 01/24/2002 | WO2000071574A3 Antigenic neisserial peptides |
| 01/24/2002 | WO2000053168A3 Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders |
| 01/24/2002 | US20020010325 Complexing; purified polypeptide |
| 01/24/2002 | US20020010321 Truncated forms of NY-ESO-1 protein |
| 01/24/2002 | US20020010318 Enzyme inhibitor; for use in treatment of lung defects, asthma, bronchitis, emphysema and respiratory system disorders |
| 01/24/2002 | US20020010317 Method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of HIV envelope proteins |
| 01/24/2002 | US20020010180 Treatment of rheumatoid arthritis, Crohn's disease, acute and chronic immune diseases associated with transplantation |
| 01/24/2002 | US20020010151 Immuno-active agent, method of its use, and method of immunity activation |
| 01/24/2002 | US20020009792 Nucleotide sequences coding protein; for use in wastewater treatment |
| 01/24/2002 | US20020009758 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/24/2002 | US20020009469 Low dose haptenized tumor cell and tumor cell extract immunotherapy |
| 01/24/2002 | US20020009468 Compositions and methods for cancer prophylaxis and/or treatment |
| 01/24/2002 | US20020009467 Antigenic substance inductor, vaccine precursor, vaccine, antibody, neutralizing antibody, antitoxin, idiotype antibody and/or anti-idiotype antibody which is induced by its idiotype antibody |
| 01/24/2002 | US20020009466 Encapsulating antigen in biopolymer |
| 01/24/2002 | US20020009465 Vaccines |
| 01/24/2002 | US20020009463 Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces |
| 01/24/2002 | US20020009462 Herpesvirus replication defective mutants |
| 01/24/2002 | US20020009461 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 01/24/2002 | US20020009459 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 01/24/2002 | US20020009458 DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 01/24/2002 | US20020009457 Water in oil emulsion |
| 01/24/2002 | US20020009456 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | US20020009450 Administering antagonist to surface receptors |
| 01/24/2002 | US20020009448 Immunology therapy |
| 01/24/2002 | US20020009446 Method of modulating memory effector T-cells and compositions |
| 01/24/2002 | US20020009444 Brain disorders using monoclonal antibodies |
| 01/24/2002 | US20020009441 Administering mixture of binding agent and active materials |
| 01/24/2002 | US20020009430 Isolation of tumor cells; incubation |
| 01/24/2002 | US20020009429 Pharmaceutical composition comprising a selected antigen and candida species antigen and methods |
| 01/24/2002 | US20020009427 Methods of therapy for non-hodgkin's lymphoma |
| 01/24/2002 | US20020009417 Nucleosome-based anti-tumor compositions |
| 01/24/2002 | DE10122233A1 Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen Using strains of Parapoxvirus ovis against organ fibrosis |
| 01/24/2002 | DE10032608A1 Für mikrosatelliteninstabile (MSI+)-Tumore relevante Gene und ihre Genprodukte For microsatellite instability (MSI +) - related tumors genes and their gene |
| 01/24/2002 | CA2418391A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | CA2416452A1 Novel proteins and nucleic acids encoding same |
| 01/24/2002 | CA2416445A1 Human rrp sequences and methods of use |
| 01/24/2002 | CA2416285A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/24/2002 | CA2415751A1 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | CA2415712A1 Protein complex serving as a vehicle for orally administerable medicaments |
| 01/24/2002 | CA2415690A1 Tetraspan protein and uses thereof |